In this issue:
Longitudinal analysis reveals high prevalence of EBV associated with MS
Safety and efficacy of teriflunomide in paediatric MS
Hydroxychloroquine for PPMS
2017 and 2010 revised McDonald criteria in predicting MS diagnosis after a CIS
Clonally expanded B cells in MS bind EBV EBNA1 and GlialCAM
BMI in adolescence and young adulthood and long-term risk of MS
Cognitive trajectories and disability progression in RRMS
Association between time spent outdoors and risk of MS
Impact of mass vaccination on SARS-CoV-2 infections among MS patients taking DMTs
Repository corticotropin injection for MS relapse not responding to corticosteroids
Please login below to download this issue (PDF)